CTOs on the Move


 
At Abaxis our mission is to supply point of care blood analyzers to the medical market and the veterinarian market. Abaxis provides leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. Abaxis is headquartered in northern California, USA, and conducts operations around the world.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.abaxis.com
  • 3240 Whipple Road
    Union City, CA USA 94587
  • Phone: 510.675.6500

Executives

Name Title Contact Details

Similar Companies

Fertility Center Laboratory

Fertility Center Laboratory is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Rose

The Rose is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IHC Skin Laser and Anti-Aging Clinic

IHC Skin Laser and Anti-Aging Clinic is a Bluffton, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Age Imaging

New Age Imaging is a Forest Hills, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CardioDX

The mission of Crescendo Bioscience, Inc. is to enable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. Crescendo Bioscience is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge. At Crescendo Bioscience, we are committed to improving rheumatologists’ ability to understand the biology underlying RA and to better determine the status of a patient’s disease. Vectra® DA is the first and only multi-biomarker blood test validated to measure RA disease activity. Vectra DA integrates the concentrations of 12 serum proteins associated with RA disease activity into a single objective score to help physicians make more informed treatment decisions. Crescendo Bioscience has also developed MyRA™, a free mobile app for people living with RA which was designed to empower patients to regularly track multiple aspects (e.g. medications, morning stiffness, joint pain, daily functionality, etc.) of their RA and easily share the information with their physician.